Andy Chevigné and his group, RTI-5152-12 is postulated to enhance the levels of opioid peptides that bind to classical opioid receptors from the brain, resulting in heightened painkilling action. The LIH-RTI study teams established a collaboration arrangement and filed a joint patent application in December 2020. Scientific American is https://alans803cyr1.mysticwiki.com/user